Japanese Clinical Practice Guide for Critical Obstetrical Hemorrhage (2017 revision)

Takeda, Satoru; Makino, Shintaro; Takeda, Jun; Kanayama, Naohiro; Kubo, Takahiko; Nakai, Asami; Suzuki, Shunji; Terui, Keita; Inaba, Shinji; Miyata, Shigeki

doi:10.1111/jog.13417

Cited by 44 publications

(69 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In COH, coagulopathy easily develops due to the physiological change of blood coagulation and fibrinolytic function in pregnant women during late pregnancy, and it is difficult to evaluate the severity due to the volume of blood loss . Blood fibrinogen concentration has been suggested as an indicator of its severity …”

Section: Introductionmentioning

confidence: 99%

Fibrinogen for the management of critical obstetric hemorrhage

Matsunaga

Takai

2018

J of Obstet and Gynaecol

Self Cite

View full text Add to dashboard Cite

The patient group for which fibrinogen concentrate works most effectively is cases with severe hypofibrinogenemia. Further research is required in the light of evidence. The essence of the transfusion algorithm in critical obstetric hemorrhage is to approach the target value for obtaining hemostasis, ensure an accurate and prompt grasp of the severity using point-of-care testing, introduce a massive transfusion protocol and use tranexamic acid.

show abstract

Section: Introductionmentioning

confidence: 99%

Fibrinogen for the management of critical obstetric hemorrhage

Matsunaga

Takai

2018

J of Obstet and Gynaecol

Self Cite

View full text Add to dashboard Cite

show abstract

“…Once hemorrhage has occurred, it is important not only to determine red blood cell (RBC) count, hemoglobin level, hematocrit value, and biochemical parameters but also to measure plasma fibrinogen levels over time by using a simple rapid fibrinogen measuring instrument as point-of-care testing in order to perform early diagnosis and treatment of coagulopathy [5,10]. In cases of massive hemorrhage, it may be difficult to assess the accurate amount of bleeding.…”

Section: Hemostatic Strategy For Massive Hemorrhage During Cesarean Smentioning

confidence: 99%

“…Administration of FFP is necessary for achieving the elevation and maintenance of blood pressure and colloid osmotic pressure. It should be noted that if the patient experiences shock, RBC transfusion alone cannot increase blood pressure; FFP and RBC should be administered at a ratio of 1:1 in the same manner as in cases of trauma [3,5,10]. In cases of consumption coagulopathy, such as in placenta abruption or amniotic fluid embolism, and coagulopathy following massive hemorrhage, the blood fibrinogen level is often <100 mg/dL.…”

Section: Hemostatic Strategy For Massive Hemorrhage During Cesarean Smentioning

confidence: 99%

“…The current revised edition of this guideline [5] recommends a new concept of obstetrical transfusion therapy, treatment of coagulopathy, and hemostatic techniques such as compression sutures, intrauterine balloon tamponade, administration of uterotonics and tranexamic acid [3,[5][6][7][8][9]. If coagulopathy is present, the fibrinogen level becomes extremely low, and reversal of hemorrhagic tendency can be achieved only by administration of cryoprecipitate or fibrinogen concentrate or transfusion of fresh-frozen plasma (FFP) [3,5,10]. In addition, simulation training for obstetrical emergency care has been conducted widely to promote good team medical care in emergency settings [1].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Hemostasis for Massive Hemorrhage during Cesarean Section

Takeda¹,

Makino²,

Takeda³

2020

Recent Advances in Cesarean Delivery

Self Cite

View full text Add to dashboard Cite

show abstract

“…10) Furthermore, organizations such as the World Health Organization (WHO), 11) the International Federation of Gynecology and Obstetrics (FIGO), 12) the American Congress of Obstetricians and Gynecologists (ACOG), 13) and the Royal College of Obstetricians and Gynaecologists (RCOG) 14) have recommended intrauterine balloons as the first-line hemostatic treatment for PPH.…”

Section: 8)mentioning

confidence: 99%

Evaluation of the effectiveness of metreurynters for balloon tamponade

Yorifuji

Takeda

Makino

et al. 2018

Hypertens Res Pregnancy

Self Cite

View full text Add to dashboard Cite

Aim: Several devices are used for balloon tamponade. In Japan, metreurynters are widely used for cervical ripening; however, there is little evidence for their use in hemostatic uterine balloon tamponade. This study aimed to assess the non-inferiority of metreurynters as the balloon device for obstetric hemorrhage. Methods: Medical charts of all patients with obstetric hemorrhage of more than 1,000 ml who underwent balloon tamponade with metreurynters were retrospectively reviewed for five years at a tertiary referral university hospital. Results: A total of 89 uterine balloon tamponade cases were identified from medical records. Of these, 66 cases involved term postpartum hemorrhage (PPH) within 24 h after delivery (PPH group) and 23 involved other types of cases (other group), including cesarean scar pregnancy, cervical pregnancy, retained placenta, and others. In the PPH group, the average hemostasis rate was 93.9%, whereas the rate was 91.3% in the other group. Seven cases failed to achieve hemostasis with balloon tamponade only and required additional treatment. There were no adverse events related to balloon tamponade using metreurynters. Conclusions: Metreurynters used for balloon tamponade were non-inferior to Bakri balloons in hemostasis and complication rates, suggesting they are effective and appropriate for the management of obstetrical hemorrhage.

show abstract

Japanese Clinical Practice Guide for Critical Obstetrical Hemorrhage (2017 revision)

Cited by 44 publications

References 0 publications

Fibrinogen for the management of critical obstetric hemorrhage

Fibrinogen for the management of critical obstetric hemorrhage

Hemostasis for Massive Hemorrhage during Cesarean Section

Evaluation of the effectiveness of metreurynters for balloon tamponade

Contact Info

Product

Resources

About